Literature DB >> 17684704

Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygium.

Arsen Akinci1, Orhan Zilelioglu.   

Abstract

PURPOSE: To compare the outcomes of use of intraoperative 0.02% mitomycin-C (MMC) and limbal-conjunctival autograft (LCAG) for treatment of primary pterygia. MATERIAL AND
METHOD: One hundred and twelve eyes of eighty patients with primary pterygia were randomly treated either by intraoperative 0.02% MMC for 5 min or LCAG. Recurrence (defined as fibrovascular tissue invading the cornea >1.5 mm) and complications were evaluated.
RESULTS: Fifty-two eyes were included in the MMC group and sixty in the LCAG group. Recurrence occurred in three eyes (5.76%) in the MMC group and in two eyes (3.33%) in the LCAG group. This difference between recurrence in the two groups was not statistically significant (P > 0.05). Incidence of complications such as conjunctival cysts, symblephara, conjunctival hyperemia, and subconjunctival hemorrhage was similar in both groups (P > 0.05) whereas corneal epithelial defects (CED), irritation, lacrimation, and photophobia were more common in the MMC group (P < 0.05).
CONCLUSION: Simple excision then intraoperative use of 0.02% (MMC) for 5 min or LCAG are similarly successful in the treatment of primary pterygia. Some complications, for example irritation, lacrimation, photophobia, and CED are more common when simple excision is followed by MMC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684704     DOI: 10.1007/s10792-007-9034-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  20 in total

1.  Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial.

Authors:  C A Manning; P M Kloess; M D Diaz; R W Yee
Journal:  Ophthalmology       Date:  1997-05       Impact factor: 12.079

2.  Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study.

Authors:  D S Lam; A K Wong; D S Fan; S Chew; P S Kwok; M O Tso
Journal:  Ophthalmology       Date:  1998-05       Impact factor: 12.079

3.  A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap.

Authors:  F M Mutlu; G Sobaci; T Tatar; E Yildirim
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

4.  Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.

Authors:  J Cano-Parra; M Diaz-Llopis; M J Maldonado; E Vila; J L Menezo
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

5.  Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C.

Authors:  P J Dougherty; D R Hardten; R L Lindstrom
Journal:  Cornea       Date:  1996-09       Impact factor: 2.651

6.  Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium.

Authors:  S Calişkan; M Orhan; M Irkeç
Journal:  Ophthalmic Surg Lasers       Date:  1996-07

7.  Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium.

Authors:  O Gris; J L Güell; Z del Campo
Journal:  Ophthalmology       Date:  2000-02       Impact factor: 12.079

8.  A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium.

Authors:  A L Young; G Y S Leung; A K K Wong; L L Cheng; D S C Lam
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

9.  Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium.

Authors:  Mashhoor F Al Fayez
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

10.  A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.

Authors:  P P Chen; R G Ariyasu; V Kaza; L D LaBree; P J McDonnell
Journal:  Am J Ophthalmol       Date:  1995-08       Impact factor: 5.258

View more
  9 in total

Review 1.  Mitomycin C in pterygium treatment.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Milton Ruiz Alves; Roger Chammas; Paulo Schor
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Novel sutureless transplantation for primary pterygium associated with cysts.

Authors:  Yi Shao; Xin Zhou; Yao Yu; Chong-Gang Pei; Qiong Zhou; Juan Li; Lu Yang; Wen-Jia Dong; Jing-Lin Yi
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

3.  Limbal stem cell transplantation: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2008-10-01

4.  [Antiangiogenic therapy for pterygium recurrence].

Authors:  S Leippi; F Grehn; G Geerling
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

5.  Bare sclera resection followed by mitomycin C and/or autograft limbus conjunctiva in the surgery for pterygium: a Meta-analysis.

Authors:  Tan Long; Zhi Li
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

6.  Analysis of recurrence patterns following pterygium surgery with conjunctival autografts.

Authors:  Soo Hyun Kwon; Hong Kyun Kim
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

7.  Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft.

Authors:  Miriam Idoipe; Borja de la Sen-Corcuera; Ronald M Sánchez-Ávila; Carmen Sánchez-Pérez; María Satué; Antonio Sánchez-Pérez; Gorka Orive; Francisco Muruzabal; Eduardo Anitua; Luis Pablo
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

8.  Simultaneous treatment of pterygium complicated with conjunctivochalasis: analysis of pterygium excision and conjunctival autotransplantation combined with sclera fixation.

Authors:  Xiao-Yi Yu; Zhan-Yu Jian; Wei Wu; Xiao-He Lu
Journal:  BMC Ophthalmol       Date:  2015-08-12       Impact factor: 2.209

9.  Simple limbal epithelial transplantation for recurrent pterygium: A case series.

Authors:  Zale Mednick; Tanguy Boutin; Adi Einan-Lifshitz; Nir Sorkin; Allan Slomovic
Journal:  Am J Ophthalmol Case Rep       Date:  2018-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.